肝癌移植后两年复发的非典型病例

Syed Muhammad Sinaan Ali , Abdul Haseeb , Muhammad Ashir Shafique , Muhammad Saqlain Mustafa , Naeemullah Arbani , Syeda Zainab Fatima
{"title":"肝癌移植后两年复发的非典型病例","authors":"Syed Muhammad Sinaan Ali ,&nbsp;Abdul Haseeb ,&nbsp;Muhammad Ashir Shafique ,&nbsp;Muhammad Saqlain Mustafa ,&nbsp;Naeemullah Arbani ,&nbsp;Syeda Zainab Fatima","doi":"10.1016/j.glmedi.2024.100101","DOIUrl":null,"url":null,"abstract":"<div><p>Hepatocellular carcinoma ranks third most common cancer worldwide. Chronic hepatitis B and C are most common cause of HCC. Liver transplantation is only curative treatment for HCC. However, recurrence post transplantation is most dreadful complication. In this case report, we presented the case of a 48-year-old South Asian patient with a history of chronic hepatitis C infection and subsequent hepatocellular carcinoma (HCC) leading to liver cirrhosis and liver failure signs and symptoms. The patient underwent liver transplantation with a right lobe graft with middle hepatic vein in 2020 which significantly improved in his condition. Two years’ post-transplant, he presented with complaints of abdominal pain radiating and shortness of breath. Radiological investigations including triphasic CT scan and ultrasonography revealed an exophytic growth from the liver and an enhancing lesion in the pre and para-vertebral area, consistent with HCC recurrence and hematoma development. The patient was managed with transarterial chemoembolization (TACE), resulting in a favorable outcome.</p></div>","PeriodicalId":100804,"journal":{"name":"Journal of Medicine, Surgery, and Public Health","volume":"3 ","pages":"Article 100101"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949916X24000549/pdfft?md5=e81d1d7171aead638b0674d600baadf4&pid=1-s2.0-S2949916X24000549-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Atypical case of hepatoma recurrence two years post-transplant\",\"authors\":\"Syed Muhammad Sinaan Ali ,&nbsp;Abdul Haseeb ,&nbsp;Muhammad Ashir Shafique ,&nbsp;Muhammad Saqlain Mustafa ,&nbsp;Naeemullah Arbani ,&nbsp;Syeda Zainab Fatima\",\"doi\":\"10.1016/j.glmedi.2024.100101\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Hepatocellular carcinoma ranks third most common cancer worldwide. Chronic hepatitis B and C are most common cause of HCC. Liver transplantation is only curative treatment for HCC. However, recurrence post transplantation is most dreadful complication. In this case report, we presented the case of a 48-year-old South Asian patient with a history of chronic hepatitis C infection and subsequent hepatocellular carcinoma (HCC) leading to liver cirrhosis and liver failure signs and symptoms. The patient underwent liver transplantation with a right lobe graft with middle hepatic vein in 2020 which significantly improved in his condition. Two years’ post-transplant, he presented with complaints of abdominal pain radiating and shortness of breath. Radiological investigations including triphasic CT scan and ultrasonography revealed an exophytic growth from the liver and an enhancing lesion in the pre and para-vertebral area, consistent with HCC recurrence and hematoma development. The patient was managed with transarterial chemoembolization (TACE), resulting in a favorable outcome.</p></div>\",\"PeriodicalId\":100804,\"journal\":{\"name\":\"Journal of Medicine, Surgery, and Public Health\",\"volume\":\"3 \",\"pages\":\"Article 100101\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2949916X24000549/pdfft?md5=e81d1d7171aead638b0674d600baadf4&pid=1-s2.0-S2949916X24000549-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medicine, Surgery, and Public Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2949916X24000549\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicine, Surgery, and Public Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949916X24000549","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

肝细胞癌是全球第三大常见癌症。慢性乙型和丙型肝炎是导致 HCC 的最常见原因。肝移植是治疗 HCC 的唯一方法。然而,移植后复发是最可怕的并发症。在本病例报告中,我们介绍了一名 48 岁南亚患者的病例,该患者有慢性丙型肝炎感染史,随后发生肝细胞癌(HCC),导致肝硬化和肝功能衰竭的症状和体征。患者于 2020 年接受了肝中静脉右叶移植手术,病情得到明显改善。移植术后两年,他主诉腹部放射痛和气短。包括三相 CT 扫描和超声波检查在内的放射学检查显示,肝脏有外生增生,椎前和椎旁区域有增强病变,符合 HCC 复发和血肿形成的情况。患者接受了经动脉化疗栓塞术(TACE),结果良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Atypical case of hepatoma recurrence two years post-transplant

Hepatocellular carcinoma ranks third most common cancer worldwide. Chronic hepatitis B and C are most common cause of HCC. Liver transplantation is only curative treatment for HCC. However, recurrence post transplantation is most dreadful complication. In this case report, we presented the case of a 48-year-old South Asian patient with a history of chronic hepatitis C infection and subsequent hepatocellular carcinoma (HCC) leading to liver cirrhosis and liver failure signs and symptoms. The patient underwent liver transplantation with a right lobe graft with middle hepatic vein in 2020 which significantly improved in his condition. Two years’ post-transplant, he presented with complaints of abdominal pain radiating and shortness of breath. Radiological investigations including triphasic CT scan and ultrasonography revealed an exophytic growth from the liver and an enhancing lesion in the pre and para-vertebral area, consistent with HCC recurrence and hematoma development. The patient was managed with transarterial chemoembolization (TACE), resulting in a favorable outcome.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信